EditorialUnderstanding peripartum cardiomyopathy, 2008
References (12)
- et al.
Seminar: peripartum cardiomyopathy
Lancet
(2006) - et al.
High prevalence of viral genomes and inflammation in peripartum cardiomyopathy
Am J Obstet Gyn
(2005) - et al.
Unrecognized peripartum cardiomyopathy in Haitian women
Int J Gynaecol Obstet
(2005) - et al.
Improved outcomes in peripartum cardiomyopathy with contemporary treatments
Am Heart J
(2006) - et al.
Subsequent pregnancy in patients with peripartum cardiomyopathy
Am J Cardiol
(2004) - et al.
Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution
Mayo Clin Proc
(2005)
Cited by (14)
Cardiomyopathy — An approach to the autoimmune background
2017, Autoimmunity ReviewsCitation Excerpt :Reflecting unpublished data from an animal study, it was suggested that the future focus of Chagas' cardiomyopathy treatment should focus on efforts to restore the immunological tolerance to self-antigens which should include trypanocidal drug treatment and an immunotherapeutic strategy such as IVIG [223]. Also, IVIG treatment was mentioned as an option for peripartum cardiomyopathy [205]. In agreement with this, 6 women vs. 11 conventionally-treated patients with peripartum cardiomyopathy demonstrated benefits as expressedby improved LVED [224].
Recovery from severe heart failure following peripartum cardiomyopathy
2009, International Journal of Gynecology and ObstetricsCitation Excerpt :Additional evaluations may include identification of anticardiac antibodies, cardiac magnetic resonance imaging, and endomyocardial biopsy to include immunohistochemical staining and polymerase chain reaction testing for viral RNA/DNA. These may lead to additional treatment modalities on a research protocol basis, such as apheresis or other immunoabsorption, or other immunomodulations including intravenous gamma globulin or antiviral treatment [10]. It is important to appreciate the overlap in initial echocardiographic parameters of LVEF and LV size when comparing outcomes.
Functional autoantibody diseases: Basics and treatment related to cardiomyopathies
2019, Frontiers in Bioscience - LandmarkPeripartum cardiomyopathy-A case report
2015, Biomedical and Pharmacology JournalRisk factors for maternal outcome in pregnancy complicated with dilated cardiomyopathy
2012, Journal of PerinatologyClinical characteristics and risk factors for peripartum cardiomyopathy
2012, African Health Sciences